Silverstein Christine Berni
SEC Form 4 insider trading activity
Silverstein Christine Berni has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.
On the most recent filing, Silverstein Christine Berni is listed as Director at ABEONA THERAPEUTICS INC. Inside the rolling window, Silverstein Christine Berni reported no open-market purchases and 2 open-market sales totaling $206K in ABEO. The largest disclosed transaction in the window is a sale of 18,160 ABEO shares on Jun 15, 2026, worth $104K.
Companies traded
Other insiders at ABEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$206K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Silverstein Christine Berni made?
Silverstein Christine Berni has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Silverstein Christine Berni trade?
Silverstein Christine Berni has filed SEC Form 4 disclosures for 1 company, including ABEO.
When was Silverstein Christine Berni's most recent SEC Form 4 filing?
Silverstein Christine Berni's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.
What is Silverstein Christine Berni's total buy and sell value in the current window?
Inside the rolling retention window, Silverstein Christine Berni bought $0 and sold $206K based on SEC Form 4 filings.
What was Silverstein Christine Berni's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,160 ABEO shares on 2026-06-15, worth $104K, per SEC Form 4 filings.